Reglan, Maxolon, Metoclopramide News

Boca Raton: Drug for heartburn, nausea not harmful to fetus, Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn, poses no significant risks for the fetus according to a large cohort study published in the June 11 issue of the New England Journal of Medicine.

According to the pediatrician and clinical pharmacologist, principal investigator Dr.

A new study is giving the thumbs up to a drug that can be used for morning sickness in pregnant women.

Main Category: Pregnancy / Obstetrics Also Included In: GastroIntestinal / Gastroenterology ; Acid Reflux / GERD ; Pediatrics / Children's Health Article Date: 12 Jun 2009 - 1:00 PDT Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published in ...

For the first time, a large study shows that pregnant women who suffer morning sickness are not risking harm to their babies if they take a certain anti-nausea drug.

The following summarizes news coverage on two pregnancy-related studies. ~ Morning sickness: The commonly prescribed heartburn drug metoclopramide -- sold generically and under the brand-names Reglan, Octamide and Maxolon -- can be used to treat morning sickness without harming the health of the fetus, according to a study published on Thursday in ...

Researchers in Israel have shown that the anti-nausea drug metoclopramide does no obvious harm to the fetus in pregnant women.

Nausea and vomiting in early pregnancy, also known as morning sickness, is a common problem affecting up to 80% of pregnant women.

A recent study from Israel, involving over 3,000 mothers who took the drug metoclopramide.

Reglan has been shown to be safe to use during early pregnancy by a large Israeli study.

Researchers at Ben Gurion University in Israel say that the findings of a new study should reassure pregnant women about the safety of taking metoclopramide to relieve morning sickness.

A heartburn treatment was found to be safe when used to relieve morning sickness in women in their first months of pregnancy, a study showed.

Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published in the June 11 issue of the prestigious New England Journal of Medicine, "The Safety of Metoclopramide Use in the First Trimester of Pregnancy" . According to the pediatrician and ...

Doctors may finally have an option to help pregnant women suffering morning sickness.

A large study shows that pregnant women who suffer morning sickness are not risking harm to their babies if they take a certain anti-nausea drug.

Use of the antiemetic metoclopramide during the first trimester of pregnancy appears to be safe for the fetus, according to a retrospective cohort study in the New England Journal of Medicine.

Taking metoclopramide to relieve nausea and vomiting during the first trimester of pregnancy does not increase the risk of birth defects and other adverse outcomes, according to a study in the June 11 issue of the New England Journal of Medicine .

A new study suggests that women who experience morning sickness early in pregnancy can safely take the medication metoclopramide to relieve their symptoms.

For the first time, a large study shows that pregnant women who suffer morning sickness are not risking harm to their babies if they take a certain anti-nausea drug.

We are about to lose another useful drug to fear. All drugs have side effects. Some are severe.